Akèy › Kansè Ipofaringe › Kansas › Kansas City
Etid klinik pou Kansè Ipofaringe nan Kansas City, KS
4 etid pou Kansè Ipofaringe ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
- University of Kansas Cancer Center, Kansas City
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Ap rekriteFaz 1
- University of Kansas Cancer Center, Kansas City
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
- University of Kansas Cancer Center, Kansas City
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Ap rekriteFaz 3
- University of Kansas Cancer Center, Kansas City
Etid Kansè Ipofaringe nan lòt vil
- Atlanta, GA6 etid
- Chicago, IL6 etid
- Richmond, VA5 etid
- Kansas City, MO5 etid
- Joliet, IL5 etid
- Milwaukee, WI5 etid
- Wausau, WI5 etid
- Cape Girardeau, MO5 etid
- Stevens Point, WI5 etid
- Peoria, IL5 etid
- Bloomington, IL5 etid
- Edison, NJ4 etid
Lòt etid nan Kansas City
- Maladi kadyovaskilè14 etid
- Ensifizyans kadyak13 etid
- Obèsite13 etid
- Maladi poumon entèstisyèl13 etid
- Fibroz sistik13 etid
- Kansè nan tete12 etid
- Kansè vejik12 etid
- Leksemi mieloïd egi12 etid
- Kansè pwostat12 etid
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon11 etid
- BPCO9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.